hoLESStolife® is the industry's first all-natural, non-prescription Cholesterol Absorption Inhibitor (CAI). ChoLESStolife® is made from plant stanols found in soybeans, which have been shown by the FDA to reduce cholesterol and the risk of heart disease, and Lecithin, a natural substance also found in soybeans, that enables cholesterol to be dispersed in water, then removed from the body.

ChoLESStolife's proprietary formulation of stanols and Lecithin (US Patent Nos. 5,932,562 and 6,063,776) has been proven clinically effective in 10 human cholesterol absorption studies and 4 chronic cholesterol reduction studies.

The studies, funded by a research grant from the National Institutes of Health and supervised by the Human Studies Committee of a major Midwestern medical school, showed that ChoLESStolife® blocks cholesterol absorption in the small intestine up to 38% and reduces LDL-cholesterol in the blood up to 14%. [American Journal of Clinical Nutrition Article, Nov. 1999]

ChoLESStolife® is designed to be taken as a dietary supplement and is currently available in tablet form. Individuals using ChoLESStolife® to manage their cholesterol levels take two tablets immediately before their breakfast and two tablets immediately before dinner.

The ChoLESStolife® approach provides individuals with a fat-free method of managing their cholesterol levels -- a significant improvement over existing oil-based strategies (margarines) that are more difficult to integrate into a healthy diet and increase an individual's caloric load.

In addition, individuals reluctant to begin drug therapy because of concerns about long-term exposure to synthetic drugs will appreciate ChoLESStolife's non-pharmaceutical approach.

Lifeline Technologies is currently selling ChoLESStolife® in one-month and three-month supply packages. Additionally, subscription plan members save even more.

ChoLESStolife® stands apart from the crowd for many reasons.

• ChoLESStolife® is the only clinically proven non-prescription fat-free Cholesterol Absorption Inhibitor (CAI) currently on the market today.
• ChoLESStolife® supplies plant stanols, which have been shown by the FDA to reduce cholesterol and the risk of heart disease.
• Other products may use solid plant sterols and stanols, but without being formulated in the ChoLESStolife® method, have been proven to have no effect on cholesterol absorption.
• ChoLESStolife’s patented technology makes soy stanols water dispersible, which allows them to be combined, and “packaged” with fat-free vehicles. This lowers caloric intake and allows their addition to a variety of food products and incorporation into tablets and capsules.
• ChoLESStolife®, unlike popular statin drugs, is free from long-term side effects because it acts locally to block cholesterol absorbtion in the small intestine. Synthetic or statin drugs are circulated throughout the entire body. That is why statin drugs are associated with side effects. Even though the reduction results may be significant, many people just can’t tolerate these drugs.
• ChoLESStolife® tablets are specially formulated to break apart and dissolve in the stomach so that they are delivered to the small intestine, where cholesterol absorption occurs, ready to begin work.
• ChoLESStolife® was funded by research grants from The National Institutes of Health.